Audited Results of Eris Lifesciences Ltd. Company

(Rs in Cr.) Mar 31, 2026 Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
Operating Income 1,821.74 1,697.75 1,486.71 1,330.72 1,215.73
Manufacturing Expenses 0 4.10 4.46 4.41 4.01
Personnel Expenses 340.62 361.92 331.67 252.52 222.18
Selling Expenses 0 0.32 3.12 3.55 6.46
Administrative Expenses 242.09 337.09 411.03 325.51 297.38
Expenses Capitalised 0 0 0 0 0
Cost Of Sales 1,209.41 1,211.20 1,032.89 825.61 731.74
Operating Profit 612.33 486.55 453.81 505.11 484
Other Recurring Income 98.31 35.51 34.83 17.26 28.99
Adjusted PBDIT 710.64 522.06 488.64 522.38 512.98
Financial Expenses 179.54 220.24 57.42 20.81 2.99
Depreciation 154.38 181.77 102.39 64.66 51.45
Other Write offs 0 0 0 0 0
Adjusted PBT 376.72 120.05 328.83 436.91 458.54
Tax Charges 118 42.66 29.12 38.90 41.35
Adjusted PAT 258.72 77.39 299.71 398.01 417.19
Non Recurring Items -14.67 -2.84 -2.76 -0.15 -1
Other Non Cash adjustments 0 0 0 0 0
Reported Net Profit 244.05 77.39 299.71 398.01 417.19
Equity Dividend 0 100.06 0 99.93 81.65
Preference Dividend 0 0 0 0 0
Retained Earnings 244.05 2,461.66 2,487.16 2,190.21 1,892.28

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+
X